Literature DB >> 5523966

Chronic allogeneic disease. II. Development of lymphomas.

M Y Armstrong, E Gleichmann, H Gleichmann, L Beldotti, J Andre-Schwartz, R S Schwartz.   

Abstract

The incidence of lymphomas in 371 CAF(1) mice injected with BALB/c spleen cells was compared with that in 324 control CAF(1) mice. A high incidence of lymphomas was found in the treated mice, but not in the control animals. The development of the neoplasms was a function of the number of parental cells administered. Analyses of the injected mice for the presence of donor cells indicated that the majority of the injected parental cells lost antihost activity, probably within 24 hr of their administration. The tumors were of host origin, as judged by transplantation tests and antigenic analysis of tumor cells.

Entities:  

Mesh:

Year:  1970        PMID: 5523966      PMCID: PMC2138811          DOI: 10.1084/jem.132.3.417

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  THE FATE OF PARENTAL PRELEUKEMIC CELLS IN LEUKEMIA-SUSCEPTIBLE AND LEUKEMIA-RESISTANT F1 HYBRID MICE.

Authors:  D METCALF
Journal:  Cancer Res       Date:  1963-12       Impact factor: 12.701

2.  A study of the graft-versus-host reaction in transplantation to embryos, F1 hybrids, and irradiated animals.

Authors:  M SIMONSEN; J ENGELBRETH-HOLM; E JENSEN; H POULSEN
Journal:  Ann N Y Acad Sci       Date:  1958-10-07       Impact factor: 5.691

3.  Splenomegaly as a host response in graft-versus-host disease.

Authors:  J G HOWARD; D MICHIE; M SIMONSEN
Journal:  Br J Exp Pathol       Date:  1961-10

4.  Tumor induction in rats by single total-body x-irradiation.

Authors:  R T BINHAMMER; J C FINERTY; M SCHNEIDER; A W CUNNINGHAM
Journal:  Radiat Res       Date:  1957-03       Impact factor: 2.841

Review 5.  Malignant lymphoproliferative diseases: interactions between immunological abnormalities and oncogenic viruses.

Authors:  R S Schwartz; J André-Schwartz
Journal:  Annu Rev Med       Date:  1968       Impact factor: 13.739

6.  Autoimmune reactions and malignant changes in germ-free New Zealand Black mice.

Authors:  J East; M Branca
Journal:  Clin Exp Immunol       Date:  1969-06       Impact factor: 4.330

7.  Reticular tumours in mice subjected to prolonged antigenic stimulation.

Authors:  D METCALF
Journal:  Br J Cancer       Date:  1961-12       Impact factor: 7.640

8.  Thymus-dependent areas in the lymphoid organs of neonatally thymectomized mice.

Authors:  D V Parrott; M A De Sousa; J East
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

9.  HOMOLOGOUS DISEASE IN THE ADULT RAT, A MODEL FOR AUTOIMMUNE DISEASE. I. GENERAL FEATURES AND CUTANEOUS LESIONS.

Authors:  P STASTNY; V A STEMBRIDGE; M ZIFF
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

10.  Chronic allogeneic disease. I. Development of glomerulonephritis.

Authors:  R M Lewis; M Y Armstrong; J André-Schwartz; A Muftuoglu; L Beldotti; R S Schwartz
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  21 in total

1.  Acceleration of autoimmunity in NZB/NZW F1 mice by graft-versus-host disease.

Authors:  R Goldblum; R Pillarisetty; M J Dauphinee; N Talal
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

2.  Endogenous RNA tumor viruses are activated during chemical induction of murine plasmacytomas.

Authors:  M Y Armstrong; P Ebenstein; W H Konigsberg; F F Richards
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  Tumor induction in host-versus-graft disease. I. Clinical and pathologic features.

Authors:  E A Cornelius
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

4.  The disease of the NZB mouse. I. Examination of ovum fusion derived tetraparental NZB:CFW chimaeras.

Authors:  R D Barnes; M Tuffrey; J Kingman; C Thornton; M W Turner
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

5.  T and B lymphocytes in New Zealand black mice. An analysis of the theta, TL and MBLA markers.

Authors:  B H Waksman; M C Raff; J East
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

6.  [Clinical manifestation and chemotherapy in Hodgkin's disease].

Authors:  C G Schmidt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

7.  The delay of leukaemia in tetraparental ovum fusion-derived AKR chimaeras.

Authors:  R D Barnes; M Tuffrey; J Kingman
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

8.  Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.

Authors:  P K Pattengale; C R Taylor
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

9.  Leukemia virus activation in chronic allogeneic disease.

Authors:  M S Hirsch; P H Black; G S Tracy; S Leibowitz; R S Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

10.  Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro.

Authors:  M S Hirsch; S M Phillips; C Solnik; P H Black; R S Schwartz; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.